Abstract: The present invention relates to compositions, methods and kits for the treatment of fibrosis. In particular, the compositions, methods and kits are particularly useful, but not limited to, the treatment of cardiac fibrosis. The invention provides a method of treating fibrosis in an individual comprising administering an AT2R selective agonist, thereby treating fibrosis.

Abstract: The present invention relates to compositions, methods and kits for the treatment of fibrosis. In particular, the compositions, methods and kits are particularly useful, but not limited to, the treatment of cardiac fibrosis. The invention provides a method of treating fibrosis in an individual comprising administering an AT2R selective agonist, thereby treating fibrosis.

Abstract: The present invention relates generally to a method of modulating T cell functional activity by utilising ?-amino acid substituted peptides and to agents useful for the same. More particularly, the present invention relates to a method of modulating class I restricted T cell activity by utilising ?-amino acid substituted peptides and to agents useful for the same. The method of the present invention is useful, inter alia, in the treatment and/or prophylaxis of conditions characterised by suboptimal T cell stimulation such as that which occurs in some viral infections and in anti-tumour immunity, as well as aberrant, unwanted or otherwise inappropriate T cell functioning such as, but not limited to, graft rejection or autoimmune conditions, the present invention is further directed to methods of identifying, designing and/or modifying agents capable of modulating T cell functional activity.

Abstract: The present invention relates to methods of processing of chemical samples containing compounds or molecular complexes using a binding material comprising a method of separating a compound or molecular complex on the basis of the ability of the compound or molecular complex to associate with a binding material, from compounds or molecular complexes having different association characteristics, said method comprising: (a) bringing a sample containing said compound or molecular complex into contact with a binding material, the binding material comprising: (i) a support, (ii) at least one terminal moiety selected from the group consisting of lecithins, lysolecithins, cephalins, sphingomyelin, cardiolipin, glycolipids, gangliosides, cerebrosides and phospholipids, and (iii) at least one linker of the formula (I) wherein R1 and R2 may be the same or different and are independently selected from the group consisting of: H, OH, C1-C6 alkyl, C2-C6 alkenyl, halogen, C1-C6 alkoxy, C2-C6 alkenyloxy and aryloxy, or

Abstract: Methods and devices for rapid screening of drug candidates, especially candidate agents for treatment of Alzheimer's disease and stroke are disclosed. The invention provides treatment compounds and a biosensor method and device which is particularly applicable to screening libraries of compounds.

Abstract: Porous zirconia or zirconium-containing particles, methods of making such particles and methods of using such particles including modifications to the surface of the particles are described. The method comprises heating zirconia particles to provide a substantially homogeneously liquid melt, quenching the particles of melt to effect spinodal decomposition to provide quench particles of a silica rich phase and a zirconia rich phase, annealing the quenched particles to provide non porous solid particles of zirconia and silica and, leaching the silica from these particles to produce porous solid zirconia particles comprising a three dimensionally substantially continuous interpenetrating network of interconnected pores.

Abstract: Porous zirconia or zirconium-containing particles, methods of making such particles and methods of using such particles including modifications to the surface of the particles are described. The method comprises heating zirconia particles to provide a substantially homogeneously liquid melt, quenching the particles of melt to effect spinodal decomposition to provide quench particles of a silica rich phase and a zirconia rich phase, annealing the quenched particles to provide non porous solid particles of zirconia and silica and, leaching the silica from these particles to produce porous solid zirconia particles comprising a three dimensionally substantially continuous inter penetrating network of interconnected pores.